The D.C. Diagnosis newsletter from STAT provides insights into the politics and policy of health and medicine. In the latest edition, the focus is on the controversy surrounding pharma-related ads during the Super Bowl. Readers are encouraged to share their thoughts on this topic, as well as any news or tips they may have.
One of the main stories highlighted in the newsletter is the potential revival of a dormant vaccine safety board by Robert F. Kennedy Jr. Senator Bill Cassidy of Louisiana has indicated his support for Kennedy’s nomination as HHS secretary, citing commitments made by the nominee. One such commitment is allowing the Senate HELP chair and physician to choose a representative for any board or commission established to review vaccine safety.
The article delves into the implications of this decision and the significance of having a dedicated board to oversee vaccine safety. Unfortunately, the rest of the article is exclusive to STAT+ subscribers, offering in-depth analysis, newsletters, premium events, and news alerts. Readers are encouraged to subscribe to STAT+ to access the full content.
Overall, the D.C. Diagnosis newsletter provides valuable insights into the latest developments in health and medicine policy. It serves as a valuable resource for those interested in staying informed about the ever-evolving landscape of healthcare in the United States.
